Genetic Technologies 6-K Indicates Co. Has Initiated Discussions With Major Cancer Organizations In US, Australia And Southeast Asia To Develop Pilot-Scale Programs For Breast Cancer Genetic Risk Assessment; Shares Now Up 6.1% For The Session